Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bone Biologics (BBLG) Payables (2016 - 2017)

Bone Biologics (BBLG) has disclosed Payables for 2 consecutive years, with $3.6 million as the latest value for Q3 2017.

  • On a quarterly basis, Payables rose 980.96% to $3.6 million in Q3 2017 year-over-year; TTM through Sep 2017 was $3.6 million, a 980.96% increase, with the full-year FY2016 number at $1.4 million, changed N/A from a year prior.
  • Payables was $3.6 million for Q3 2017 at Bone Biologics, up from $2.5 million in the prior quarter.
  • In the past five years, Payables ranged from a high of $3.6 million in Q3 2017 to a low of $335622.0 in Q3 2016.